This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shotelersuk K et al. (2000) Epstein–Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res 3: 1046–1051
Hsiao JR et al. (2002) Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Cancer 94: 723–729
Lo YM et al. (1999) Quantitative and temporal correlation between circulating cell-free Epstein–Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 59: 5452–5455
Chan AT et al. (2002) Plasma Epstein–Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94: 1614–1619
Wei WI et al. (2004) Quantitative analysis of plasma cell-free Epstein–Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study. Head Neck 10: 878
Fan H et al. (2004) Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein–Barr virus. Int J Cancer 112: 1036–1041
Acknowledgements
The synopsis was written by David Bruce, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Farrell, P. Can plasma Epstein–Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?. Nat Rev Clin Oncol 2, 14–15 (2005). https://doi.org/10.1038/ncponc0051
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0051